Gary N. Holland

发表

The Safety of Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis and Incidence of Immune Recovery Uveitis Following Potent Antiretroviral Therapy

S. Spector, K. Squires, M. Jacobson, 2005, HIV clinical trials.

Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.

R. Gale, R. Busuttil, R. Champlin, 1988, Reviews of infectious diseases.

Reconsidering the pathogenesis of ocular toxoplasmosis.

G. Holland, Gary N. Holland, 1999, American journal of ophthalmology.

Glaucoma in patients with uveitis.

R. E. Christensen, G. Holland, D. Lee, 1990, The British journal of ophthalmology.

Cytomegalovirus retinopathy as the initial manifestation of the acquired immunodeficiency syndrome.

M. Gottlieb, G. Holland, N. Wheeler, 1991, American journal of ophthalmology.

Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome.

G. Holland, W. Johnston, R. Engstrom, 1993, American journal of ophthalmology.

Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis.

G. Holland, R. Webster, B. Mondino, 1997, Ophthalmology.

Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis.

G. Holland, C. Muccioli, G. O'Connor, 1999, American journal of ophthalmology.

Tubulointerstitial nephritis and uveitis syndrome: recognizing the importance of an uncommon disease.

R. Levinson, J. Mandeville, Gary N. Holland, 2000, American journal of ophthalmology.